{"id":"W2109195714","doi":"10.1016/j.bbmt.2013.07.020","title":"Prevalence of Hematopoietic Cell Transplant Survivors in the United States","year":2013,"lang":"en","type":"article","venue":"Biology of Blood and Marrow Transplantation","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":254,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Hospital","funders":"National Institute of Allergy and Infectious Diseases; National Cancer Institute; Office of Naval Research; National Heart, Lung, and Blood Institute; Takeda Oncology; Health Resources and Services Administration; Therakos; Sigma-Tau Pharmaceuticals; Kiadis Pharma; Genentech; CellGenix; Medical College of Wisconsin; Tarix Pharmaceuticals; StemCyte; Blue Cross and Blue Shield Association; Swedish Orphan Biovitrum; Emory University; Teva Pharmaceutical Industries; WellPoint; HistoGenetics; Otsuka America; U.S. Navy; Osiris Therapeutics; Celgene; Amgen; Ariad Pharmaceuticals; U.S. Department of Defense; Sanofi; U.S. Department of Health and Human Services; GlaxoSmithKline","keywords":"Medicine; Hematopoietic cell; Specialty; Cohort; Population; Health care; Transplantation; Family medicine; Bone transplantation; Bone marrow transplant; Gerontology; Pediatrics; Internal medicine; Bone marrow transplantation; Stem cell; Haematopoiesis; Surgery; Environmental health","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002347627,0.00008390196,0.0001796662,0.0001423041,0.00001697394,0.000002326725,0.00008548141,0.00008770666,0.00003649396],"category_scores_gemma":[0.000008413036,0.00005329819,0.00002831291,0.0001598441,0.0002157547,0.00003432068,0.000003368961,0.00009013397,0.00000187572],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000005023612,"about_ca_system_score_gemma":0.00004933327,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001887986,"about_ca_topic_score_gemma":0.00005413662,"domain_scores_codex":[0.9992195,0.0001319959,0.0002598404,0.0001305621,0.0001111069,0.0001469497],"domain_scores_gemma":[0.9993781,0.0003655056,0.00006093891,0.0001033756,0.00005716772,0.0000348567],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0004413877,0.0003836076,0.3885005,0.006760376,0.00006923427,0.00003343434,0.01147102,0.00001537739,0.591589,0.0003791336,0.00003220605,0.0003247268],"study_design_scores_gemma":[0.01267342,0.002638407,0.4371791,0.0009846154,0.001199731,0.0007272443,0.002280917,0.001533711,0.5390093,0.001421903,0.00004626142,0.0003053457],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9982585,0.0003970664,0.0003292276,0.0003444722,0.00001589357,0.0003878257,0.0000683722,0.000006784809,0.0001918422],"genre_scores_gemma":[0.9945008,0.004986961,0.0001974325,0.0000779945,0.00000699546,0.00002430701,0.0001721825,0.000005302039,0.00002801606],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.05257965,"threshold_uncertainty_score":0.2854083,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01057182767153208,"score_gpt":0.2460921251503561,"score_spread":0.235520297478824,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}